# Pharma & Life Sciences Insights Program: Technological Triumphs

**LVCC, Lvl 3, Rm 325-327**  
**October 8, 2023**  
**Mike Montello, GSK**  
**Mary Rozenman, PhD, insitro**  
**Alex Snyder, MD, Generate Biomedicines**

HTLH sessions summaries are sponsored by Abridge, the leader in real-time generative AI for clinical documentation. For a demo of the Abridge solution - used by thousands of clinicians every day - see us at booth 5923. Video summaries are generated by a third party.

The speakers discussed the applications of artificial intelligence (AI) and emerging technologies in their organizations, specifically in the pharmaceutical sector. They talked about how these technologies are being used in everything from identifying targets for treatment to running clinical trials and regulatory submissions. The panelists highlighted the importance of the data used by AI and the need for high-quality data. Also, they discussed the need for partnerships and collaboration in this field. They highlighted some challenges in adopting these technologies, including the need for a skilled workforce, regulatory barriers, and the importance of clear and transparent communication about the potential of these technologies. The speakers emphasized that while there is great potential, it is crucial to manage expectations and avoid overstating what these technologies can do.

The HLTH team is processing the video. Your summary will be ready soon. Check back later.